Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $1.417B (100.0% shares, 0.0% debt)

Holdings (29)

VTI VANGUARD INDEX FDS 22.3%

Value $316M Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 10.2%

Value $144M Shares 2,330,830 Est. Cost $22.16 Unrealized +66.6%

ASML ASML HOLDING N V 9.4%

Value $133M Shares 165,836 Est. Cost $662.32 Unrealized —

CRM SALESFORCE INC 6.4%

Value $90.04M Shares 330,187 Est. Cost $205.72 Unrealized +29.3%

MIRM MIRUM PHARMACEUTICALS INC 5.4%

Value $76.34M Shares 1,500,055 Est. Cost $12.27 Unrealized +263.0%

EWTX EDGEWISE THERAPEUTICS INC 5.0%

Value $70.14M Shares 5,350,000 Est. Cost $18.02 Unrealized -20.0%

INSM INSMED INC 4.8%

Value $68.44M Shares 680,000 Est. Cost $23.10 Unrealized +231.0%

RXRX RECURSION PHARMACEUTICALS IN 3.5%

Value $48.91M Shares 9,665,128 Est. Cost $6.72 Unrealized -26.9%

CRNX CRINETICS PHARMACEUTICALS IN 3.1%

Value $44.58M Shares 1,550,000 Est. Cost $25.06 Unrealized +23.2%

BABA ALIBABA GROUP HLDG LTD 3.0%

Value $42.23M Shares 372,327 Est. Cost $165.09 Unrealized —

AVBP ARRIVENT BIOPHARMA INC 2.9%

Value $40.76M Shares 1,872,142 Est. Cost $20.52 Unrealized +1.2%

— MERUS N V 2.8%

Value $39.45M Shares 750,000 Est. Cost $56.95 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 2.6%

Value $36.28M Shares 660,000 Est. Cost $77.70 Unrealized -24.2%

— BLUEPRINT MEDICINES CORP 2.4%

Value $33.96M Shares 264,956 Est. Cost $74.93 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 2.3%

Value $33.27M Shares 2,380,000 Est. Cost $16.63 Unrealized -18.4%

PHVS PHARVARIS N V 2.1%

Value $30.36M Shares 1,725,000 Est. Cost $15.26 Unrealized +5.6%

PCVX VAXCYTE INC 2.1%

Value $29.78M Shares 916,160 Est. Cost $39.88 Unrealized -17.8%

CLDX CELLDEX THERAPEUTICS INC NEW 1.7%

Value $24.42M Shares 1,200,000 Est. Cost $34.88 Unrealized -44.2%

ZBIO ZENAS BIOPHARMA INC 1.5%

Value $21.8M Shares 2,250,000 Est. Cost $14.60 Unrealized -33.3%

ELVN ENLIVEN THERAPEUTICS INC 1.5%

Value $21.75M Shares 1,084,432 Est. Cost $18.93 Unrealized 0.0%

APGE APOGEE THERAPEUTICS INC 1.4%

Value $19.52M Shares 449,392 Est. Cost $38.04 Unrealized 0.0%

CBLL CERIBELL INC 1.2%

Value $16.86M Shares 900,000 Est. Cost $23.95 Unrealized -29.0%

VALN VALNEVA SE 1.0%

Value $13.47M Shares 2,375,000 Est. Cost $5.67 Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%

Value $7.42M Shares 2,000,000 Est. Cost $14.31 Unrealized -75.4%

IOBT IO BIOTECH INC 0.3%

Value $4.663M Shares 3,354,449 Est. Cost $6.26 Unrealized -81.7%

— LANZATECH GLOBAL INC 0.3%

Value $4.289M Shares 15,814,845 Est. Cost $3.88 Unrealized —

MQ MARQETA INC 0.2%

Value $2.574M Shares 441,558 Est. Cost $22.37 Unrealized -78.8%

ABCL ABCELLERA BIOLOGICS INC 0.2%

Value $2.238M Shares 652,529 Est. Cost $8.47 Unrealized -70.6%

GLTO GALECTO INC 0.0%

Value $341K Shares 99,913 Est. Cost $13.05 Unrealized -77.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$316M	22.3%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	2,330,830	$144M	10.2%	$22.16	+66.6%	CL A LTD VT SH	11271J107
ASML	ASML HOLDING N V	165,836	$133M	9.4%	$662.32	—	N Y REGISTRY SHS	N07059210
CRM	SALESFORCE INC	330,187	$90.04M	6.4%	$205.72	+29.3%	COM	79466L302
MIRM	MIRUM PHARMACEUTICALS INC	1,500,055	$76.34M	5.4%	$12.27	+263.0%	COM	604749101
EWTX	EDGEWISE THERAPEUTICS INC	5,350,000	$70.14M	5.0%	$18.02	-20.0%	COM	28036F105
INSM	INSMED INC	680,000	$68.44M	4.8%	$23.10	+231.0%	COM PAR $.01	457669307
RXRX	RECURSION PHARMACEUTICALS IN	9,665,128	$48.91M	3.5%	$6.72	-26.9%	CL A	75629V104
CRNX	CRINETICS PHARMACEUTICALS IN	1,550,000	$44.58M	3.1%	$25.06	+23.2%	COM	22663K107
BABA	ALIBABA GROUP HLDG LTD	372,327	$42.23M	3.0%	$165.09	—	SPONSORED ADS	01609W102
AVBP	ARRIVENT BIOPHARMA INC	1,872,142	$40.76M	2.9%	$20.52	+1.2%	COM	04272N102
—	MERUS N V	750,000	$39.45M	2.8%	$56.95	—	COM	N5749R100
BMRN	BIOMARIN PHARMACEUTICAL INC	660,000	$36.28M	2.6%	$77.70	-24.2%	COM	09061G101
—	BLUEPRINT MEDICINES CORP	264,956	$33.96M	2.4%	$74.93	—	COM	09627Y109
VRDN	VIRIDIAN THERAPEUTICS INC	2,380,000	$33.27M	2.3%	$16.63	-18.4%	COM	92790C104
PHVS	PHARVARIS N V	1,725,000	$30.36M	2.1%	$15.26	+5.6%	COM	N69605108
PCVX	VAXCYTE INC	916,160	$29.78M	2.1%	$39.88	-17.8%	COM	92243G108
CLDX	CELLDEX THERAPEUTICS INC NEW	1,200,000	$24.42M	1.7%	$34.88	-44.2%	COM NEW	15117B202
ZBIO	ZENAS BIOPHARMA INC	2,250,000	$21.8M	1.5%	$14.60	-33.3%	COM	98937L105
ELVN	ENLIVEN THERAPEUTICS INC	1,084,432	$21.75M	1.5%	$18.93	0.0%	COM	29337E102
APGE	APOGEE THERAPEUTICS INC	449,392	$19.52M	1.4%	$38.04	0.0%	COM	03770N101
CBLL	CERIBELL INC	900,000	$16.86M	1.2%	$23.95	-29.0%	COM	15678C102
VALN	VALNEVA SE	2,375,000	$13.47M	1.0%	$5.67	—	SPONSORED ADS	92025Y103
FDMT	4D MOLECULAR THERAPEUTICS IN	2,000,000	$7.42M	0.5%	$14.31	-75.4%	COM	35104E100
IOBT	IO BIOTECH INC	3,354,449	$4.663M	0.3%	$6.26	-81.7%	COM	449778109
—	LANZATECH GLOBAL INC	15,814,845	$4.289M	0.3%	$3.88	—	COM	51655R101
MQ	MARQETA INC	441,558	$2.574M	0.2%	$22.37	-78.8%	CLASS A COM	57142B104
ABCL	ABCELLERA BIOLOGICS INC	652,529	$2.238M	0.2%	$8.47	-70.6%	COM	00288U106
GLTO	GALECTO INC	99,913	$341K	0.0%	$13.05	-77.3%	COM NEW	36322Q206